Titleist Asset Management »

Halozyme Therapeutics shares owned by Titleist Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Titleist Asset Management from 13F filings

Historical chart of Titleist Asset Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Titleist Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Titleist Asset Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $273k 4.8k 56.90
2022-06-30 $211k 4.8k 44.01

More positions owned by Titleist Asset Management

Trueshares Low Volatility Equity Income Etf Trueshares Lw Vo (DIVZ)
Tesla Motors (TSLA)
Spdr S&p 500 Etf Trust Tr Unit (SPY)
Moderna (MRNA)
Invesco S&p 500 Equal Weight Etf S&p500 Eql Wgt (RSP)
Asml Holding N V N Y Registry Ny Registry Shs (ASML)
The Trade Desk Inc Com Cl A Cl A (TTD)
Apple (AAPL)
Wisdomtree Us Quality Dividend Growth Fund Us Qtly Div Grt (DGRW)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
Illumina (ILMN)
Ishares Core S&p Mid-cap Etf Core S&p Mcp Etf (IJH)
Invesco Qqq Trust Unit Ser 1 (QQQ)
Schwab Us Dividend Equity Etf Us Dividend Eq (SCHD)
Shopify Inc Cl A Cl A (SHOP)

View all positions for Titleist Asset Management

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
State Street Corporation
Snyder Capital Management
Alliancebernstein
Artisan Partners Limited Partnership
Geode Capital Management
Macquarie Group
Jpmorgan Chase & Co
Bank of America Corporation
Arrowpoint Asset Management
Goldman Sachs Group
Congress Asset Management
Invesco
Dimensional Fund Advisors

View all funds holding Halozyme Therapeutics